Study Reveals Limited Benefits of Medical Cannabis for Mental Health
This medical cannabis efficacy review reveals limited benefits for psychiatric conditions such as anxiety and depression. Clinicians should counsel patients carefully about cannabis use given the sparse robust evidence. The findings emphasize cautious…
Cannabinoids for Mental, Substance Use Disorders ‘Rarely Justified,’ Study Suggests
This article reviews cannabinoid clinical trials mental disorders evidence indicating limited efficacy for mental health and substance use disorders. The findings suggest cannabinoids offer minimal benefit for cannabis withdrawal and no advantage over…
Study Found CBD and CBG May Counter Fatty Liver Disease | Cannabis Sciences
Emerging research highlights hepatoprotective effects CBD CBG may provide in managing fatty liver disease. These cannabinoids show potential in reducing liver fat and improving function. Clinicians should consider this early evidence cautiously while…
‘No evidence’ cannabis works for most mental health disorders: Review – RACGP
This review highlights cannabis mental health conditions treatment lacks sufficient evidence for efficacy. Despite widespread use, most psychiatric disorders show no proven benefit. Clinicians must counsel patients on risks and evidence gaps.
Using Marijuana to Ease Anxiety or Depression? Science Shows the Evidence Isn’t There
Cannabis use for anxiety and depression is increasingly common, but current evidence does not support its efficacy. Research shows mixed or inconclusive results for cannabis in mood disorders. Clinicians should counsel patients on the lack of proven…
Two newly released analyses of existing research have found no evidence that marijuana is …
Recent analyses highlight that cannabis efficacy anxiety depression is not supported by sufficient evidence. Patients often self-medicate with marijuana despite lacking efficacy data. Clinicians should counsel patients on evidence-based treatments and…
Cannabis Shows Little Benefit for Most Mental Disorders, Data Review Finds
Current evidence shows cannabis mental health risk outweighs benefits for most psychiatric disorders. Despite patient interest, cannabis demonstrates minimal efficacy for anxiety and depression. Clinicians should counsel patients on limited benefits and…
Surprising Findings on Cannabis and Cognitive Outcomes in Older Adults
Recent research on cannabis cognitive outcomes older adults challenges previous adolescent-focused findings. Older adults may experience different cognitive effects from cannabis use, highlighting the need for age-specific clinical guidance. This…
Lancet Reveals Key Findings on Medicinal Cannabis and Mental Health
This cannabinoid safety and efficacy mental health study offers clinicians crucial evidence for prescribing medicinal cannabis in psychiatric conditions. The Lancet review synthesizes scattered data to inform safer clinical decisions. It highlights both…
Using marijuana to ease anxiety or depression? Science shows the evidence isn’t there
Recent studies show cannabis for psychiatric symptoms lacks strong evidence for anxiety or depression relief. Patients often self-medicate, risking delayed effective treatments. Clinicians should guide patients toward proven therapies instead of cannabis.
